Pyridoxal 5'-phosphate-dependent catalytic antibody

Area of Science:

• Biochemistry
• Immunology
• Enzyme catalysis

Background:

• Cofactors can enhance the catalytic abilities of antibodies.
• Pyridoxal 5 -phosphate (PLP) is a crucial cofactor in numerous biochemical reactions.
• Antibodies can be engineered to perform specific enzymatic functions.

Purpose of the Study:

• To screen monoclonal antibodies for their ability to bind PLP-related compounds and catalyze PLP-dependent reactions.
• To identify and characterize an antibody with cofactor-dependent catalytic activity.
• To investigate the role of PLP in enhancing antibody catalytic efficiency and specificity.

Main Methods:

• Screening monoclonal antibodies against Nalpha-phosphopyridoxyl-L-lysine.
• Assessing antibody binding to 5 -phosphopyridoxyl amino acids and PLP-amino acid Schiff bases.
• Testing antibody catalysis of PLP-dependent alpha,beta-elimination reactions using beta-chloro-D/L-alanine.
• Characterizing the transamination activity of the selected antibody with D-amino acids and oxo acids.

Main Results:

• Antibody 15A9 met all screening criteria, demonstrating binding and catalytic activity.
• Antibody 15A9 specifically catalyzes the transamination of hydrophobic D-amino acids and oxo acids with a kcat of 0.42 min-1.
• PLP significantly enhances catalytic efficacy (10(4) times more efficient than pyruvate) and antibody acceleration (5 x 10(3) fold).

Conclusions:

• Antibody 15A9 functions as a PLP-dependent enzyme, catalyzing specific transamination reactions.
• The antibody demonstrates high specificity, stereospecificity, and substrate selectivity in its catalytic action.
• Engineered antibodies can effectively utilize cofactors to achieve efficient and specific enzymatic catalysis.